Login / Signup

New Derivatives of the Multi-Stage Active Malaria Box Compound MMV030666 and Their Antiplasmodial Potencies.

Theresa HermannRobin WallnerJohanna DolenskyWerner SeebacherEva-Maria Pferschy-WenzigMarcel KaiserPascal MäserRobert Weis
Published in: Pharmaceuticals (Basel, Switzerland) (2022)
MMV's Malaria Box compound MMV030666 shows multi-stage activity against various strains of Plasmodium falciparum and lacks resistance development. To evaluate the importance of its diarylether partial structure, diarylthioethers and diphenylamines with varying substitution patterns were prepared. A number of evident structure-activity relationships were revealed. Physicochemical and pharmacokinetic parameters were determined experimentally (passive permeability) or calculated. Compared to the lead compound a diarylthioether was more active and less cytotoxic resulting in an excellent selectivity index of 850. In addition, pharmacokinetic and physicochemical parameters were improved.
Keyphrases
  • plasmodium falciparum
  • transcription factor
  • binding protein
  • escherichia coli
  • single cell
  • structural basis
  • structure activity relationship